Lung transplantation in patients with cystic fibrosis: special focus to infection and comorbidities

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Expert Review of Respiratory Medicine

• Publication date

  2014-05-16

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1586/17476348.2014.899906PMID 24655065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of nutritional status and dietetic interventions on survival in Cystic Fibrosis patients before and after lung transplantation.

  2014cited by this paper
• Impact of pulmonary hypertension on survival in patients with cystic fibrosis undergoing lung transplantation: an analysis of the UNOS registry.

  2014cited by this paper
• Pretransplant Aspergillus Colonization of Cystic Fibrosis Patients and the Incidence of Post–Lung Transplant Invasive Aspergillosis

  2014cited by this paper
• Extracorporeal membrane oxygenation as bridge to lung transplantation.

  2013cited by this paper
• Should adults with cystic fibrosis receive lung transplants?. Outcomes versus progression of disease.

  2013cited by this paper
• Lung transplant outcomes in cystic fibrosis patients with pre‐operative Mycobacterium abscessus respiratory infections

  2013cited by this paper
• Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States.

  2013cited by this paper
• Survival of cystic fibrosis patients undergoing liver and liver-lung transplantations.

  2013cited by this paper
• Peri-lung transplant renal issues in patients with cystic fibrosis.

  2013cited by this paper
• Nontuberculous mycobacterial disease is not a contraindication to lung transplantation in patients with cystic fibrosis: a retrospective analysis in a Danish patient population.

  2013cited by this paper
• Body mass index and its effect on outcome in children after lung transplantation.

  2013cited by this paper
• Reduction of lipid‐laden macrophage index after laparoscopic Nissen fundoplication in cystic fibrosis patients after lung transplantation

  2013cited by this paper
• Survival benefit of lung transplant for cystic fibrosis since lung allocation score implementation.

  2013cited by this paper
• Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation.

  2013cited by this paper
• Impact of medication non-adherence on survival after pediatric heart transplantation in the U.S.A.

  2013cited by this paper
• Experience of extracorporeal membrane oxygenation as a bridge to lung transplantation in France.

  2013influential reference
• Antithymocyte globulin induction therapy improves survival in lung transplantation for cystic fibrosis

  2013influential reference
• The impact of medication adherence on lung health outcomes in cystic fibrosis

  2013cited by this paper
• Risk factors and outcomes in lung transplant recipients with nodular invasive pulmonary aspergillosis.

  2013cited by this paper
• Targeted Antibiotic Prophylaxis for Lung Transplantation in Cystic Fibrosis Patients Colonised with Pseudomonas aeruginosa Using Multiple Combination Bactericidal Testing

  2012cited by this paper
• Pulmonary hypertension is associated with higher mortality in cystic fibrosis patients awaiting lung transplantation.

  2012cited by this paper
• Risk of post-lung transplant renal dysfunction in adults with cystic fibrosis.

  2012cited by this paper
• Outcome of Cystic Fibrosis-Related Diabetes Two Years after Lung Transplantation

  2012cited by this paper
• Lung Transplantation in Patients With Prior Cardiothoracic Surgical Procedures

  2012cited by this paper
• The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012.

  2012influential reference
• Extracorporeal Membrane Oxygenation: Indications and Contraindications

  2012cited by this paper
• Gastroesophageal reflux disease in lung transplant patients with cystic fibrosis.

  2012cited by this paper
• Pulmonary hypertension is associated with higher mortality in cystic fibrosis patients awaiting lung transplantation.

  2012cited by this paper
• Diabetes before and after lung transplantation in patients with cystic fibrosis and other lung diseases

  2012cited by this paper
• Diabetes mellitus and survival in cystic fibrosis patients after lung transplantation.

  2012cited by this paper
• Post-transplant lymphoproliferative disorder after lung transplantation: a review of 35 cases.

  2012cited by this paper
• Ambulatory venovenous extracorporeal respiratory support as a bridge for cystic fibrosis patients to emergent lung transplantation.

  2012cited by this paper
• Outcomes of patients with cystic fibrosis undergoing lung transplantation with and without cystic fibrosis‐associated liver cirrhosis *

  2012cited by this paper
• Colon cancer in lung transplant recipients with CF: increased risk and results of screening.

  2011cited by this paper
• Antireflux surgery preserves lung function in patients with gastroesophageal reflux disease and end-stage lung disease before and after lung transplantation.

  2011cited by this paper
• Risk factors for chronic kidney disease in adults with cystic fibrosis.

  2011cited by this paper
• Extracorporeal membrane oxygenation as a bridge to lung transplant: midterm outcomes.

  2011cited by this paper
• Liver transplantation in patients with cystic fibrosis: Analysis of united network for organ sharing data

  2011cited by this paper
• Usefulness of extracorporeal membrane oxygenation as a bridge to lung transplantation: a descriptive study.

  2011cited by this paper
• Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder ★

  2011cited by this paper
• Prevalence of pulmonary hypertension in end-stage cystic fibrosis and correlation with survival.

  2010cited by this paper
• Epidemiology, Pathophysiology, and Prognostic Implications of Cystic Fibrosis–Related Diabetes

  2010cited by this paper
• Ambulatory extracorporeal membrane oxygenation: a new approach for bridge-to-lung transplantation.

  2010cited by this paper
• Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience.

  2010cited by this paper
• Body composition assessed by the 4-component model and association with lung function in 6-12-y-old children with cystic fibrosis.

  2010cited by this paper
• The impact of recipient body mass index on survival after lung transplantation.

  2010cited by this paper
• Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax.

  2010cited by this paper
• Obesity and underweight are associated with an increased risk of death after lung transplantation.

  2009cited by this paper
• Effect of Adherence to Home Spirometry on Bronchiolitis Obliterans and Graft Survival After Lung Transplantation

  2009cited by this paper
• Cystic Fibrosis

  2009cited by this paper
• Cystic fibrosis

  2009cited by this paper
• Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex.

  2008cited by this paper
• Impact of burkholderia infection on lung transplantation in cystic fibrosis.

  2008influential reference
• Case-control study of acute renal failure in patients with cystic fibrosis in the UK

  2008cited by this paper
• Gastro-oesophageal reflux and aspiration of gastric contents in adult patients with cystic fibrosis

  2008cited by this paper
• Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres

  2008cited by this paper
• Lung transplantation and survival in children with cystic fibrosis.

  2007cited by this paper
• Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria.

  2007influential reference
• Development of the New Lung Allocation System in the United States

  2006influential reference
• Mycobacterium abscessus chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient.

  2006cited by this paper
• Mycobacterium abscessus infections in lung transplant recipients: the international experience.

  2006cited by this paper
• Gastroesophageal reflux (symptomatic and silent): a potentially significant problem in patients with cystic fibrosis before and after lung transplantation.

  2005cited by this paper
• Acute Renal Failure after Lung Transplantation: Incidence, Predictors and Impact on Perioperative Morbidity and Mortality

  2005cited by this paper
• Age-Related Prevalence and Distribution of Nontuberculous Mycobacterial Species among Patients with Cystic Fibrosis

  2005cited by this paper
• Use of lung transplantation survival models to refine patient selection in cystic fibrosis.

  2005cited by this paper
• A survey of clinical practice of lung transplantation in North America.

  2004cited by this paper
• Epidemiology of liver disease in cystic fibrosis: a longitudinal study.

  2004cited by this paper
• Joint Modeling of Longitudinal and Time-to-Event Data : An Overview

  2004cited by this paper
• The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre.

  2004cited by this paper
• Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.

  2003cited by this paper
• Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation.

  2003cited by this paper
• A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients1

  2003cited by this paper
• Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients.

  2003cited by this paper
• Liver cirrhosis and portal hypertension in cystic fibrosis

  2003cited by this paper
• Assessment of survival benefit after lung transplantation by patient diagnosis.

  2002cited by this paper
• Transplantation for cystic fibrosis: Outcome following early liver transplantation

  2002cited by this paper
• Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients

  2002cited by this paper
• Impact of body weight on long-term survival after lung transplantation.

  2002cited by this paper
• Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre

  2002cited by this paper
• Outcome of lung transplantation in patients with mycetomas.

  2002cited by this paper
• Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation.

  2001cited by this paper
• Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type.

  2001cited by this paper
• Fatal Pulmonary Infection Due to Multidrug-Resistant Mycobacterium abscessus in a Patient with Cystic Fibrosis

  2001cited by this paper
• Survival effect of lung transplantation among patients with cystic fibrosis.

  2001cited by this paper
• Predictive 5-year survivorship model of cystic fibrosis.

  2001cited by this paper
• LOW RATE OF ACUTE LUNG ALLOGRAFT REJECTION AFTER THE USE OF DACLIZUMAB, AN INTERLEUKIN 2 RECEPTOR ANTIBODY

  2001cited by this paper
• Nutritional assessment of the lung transplant patient: body mass index as a predictor of 90-day mortality following transplantation.

  2001cited by this paper
• Prevalence and consequences of nutritional depletion in lung transplant candidates.

  2000cited by this paper
• Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates.

  2000cited by this paper
• The spectrum of mycobacterial infection after lung transplantation.

  1999cited by this paper
• Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: results of a randomized, prospective study.

  1999cited by this paper
• Pulmonary aspergillosis in cystic fibrosis lung transplant recipients.

  1998cited by this paper
• International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation.

  1998influential reference
• Successful lung transplantation in spite of cystic fibrosis-associated liver disease: a case series.

  1997cited by this paper
• The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome.

  1997cited by this paper
• Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naïve lung transplant recipient.

  1996cited by this paper
• Acute rejection of lung allografts with various immunosuppressive protocols.

  1992cited by this paper

• Bacterial infections in lung transplantation

  2021cites this paper
• [Selection of lung transplant candidates in France in 2019].

  2019cites this paper
• PATHOGENESIS : THE IMPORTANCE OF ROUGH AND SMOOTH COLONY PHENOTYPES

  2018cites this paper
• Lung transplantation in cystic fibrosis patients with difficult to treat lung infections

  2017cites this paper
• Substantial Increases Occur in Serum Activins and Follistatin during Lung Transplantation

  2016cites this paper
• Lung Transplantation for Cystic Fibrosis: Results, Indications, Complications, and Controversies

  2015cites this paper
• Surgeon's viewpoint on lung transplantation in cystic fibrosis patients - preliminary report.

  2015cites this paper
• Successful surgical management of early esophageal cancer in a patient with cystic fibrosis post-bilateral lung transplantation

  2015cites this paper